Breast Myoid Hamartoma (MH) is a rare type of neoplasm with
a poorly understood pathogenesis. Very few literatures have reported such
disease with an unclear prognosis and malignant potentiality. Some isolated
studies have shown that breast Myoid Hamartoma (MH) may be genetically related
to other types of tumours with the involvement of HMGA2 gene. We reported a
case of a 64-year-old post-menopausal lady with an underlying chronic
idiopathic axonal polyneuropathy (CIAP) that was referred to our centre for a
suspected right breast tumour. Clinical and imaging proved the disease to be
malignant, however, core biopsy results showed otherwise. Ultrasound of the
right breast showed a solid mass with a hypoechoic heterogeneous echotexture
and posterior shadowing. A Mammogram highlighted a dense lesion in the right
breast with radiolucent halo and macrocalcification. It was reported as BIRADS
4 category. Managing breast Myoid Hamartoma (MH) is proved to be of great
challenge to clinicians as meticulous clinical acumen is needed to strategize a
proper plan and management, most importantly, not to overlook the disease as
the malignant transformation has been reported before.
Author(s) Details:
Mohamed Shafi Mahboob Ali,
Department of General Surgery, Advanced Medical and Dental Institute
(AMDI), Malaysia.
Please see the link here: https://stm.bookpi.org/ANUMS-V5/article/view/13341
No comments:
Post a Comment